Effects of Baicalin on Pharmacokinetics of Florfenicol and mRNA Expression of CYP1A2, CYP2C11, CYP3A1, UGT1A1, MDR1, and ABCC2 in Rats
Si‑Cong Li2,3, Xu‑Ting Li2,3★, Bin Wang2,3, Rui Yang2,3, Min Zhang2,3, Jin‑Liang Li2,3, Wei Huang4, Liang Cao4, Song‑Yang Xiao4★ Corresponding author
- 1Institute of Veterinary Pharmacology, Sichuan Animal Science Academy, China.
- 2Animal Breeding and Genetics Key Laboratory of Sichuan Province, China.
- 3Sichuan Dingjian Animal Pharmaceutical Co., Ltd., Chengdu, PR, China.
CORRESPONDENCE
Xu‑Ting Li
Animal Breeding and Genetics Key Laboratory of Sichuan Province, China.
Received: 21-06-2019; Revised: 22-08-2019.
Volume 16, Issue 67 · pp. 1–6 · PUBLISHED 11 February 2020 · DOI: 10.4103/pm.pm_261_19
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: The traditional Chinese medicine Scutellariae radix is often used in combination with antibiotics, such as florfenicol, in Chinese veterinary medicine. Baicalin (5, 6, 7‑trihydroxyflavone‑7‑β‑D‑glucu ronide) is the main active constituent of S. radix. The effects of baicalin on the pharmacokinetics of florfenicol are not known. Thus, we have studied the effects of baicalin on florfenicol pharmacokinetics and the mRNA expression of drug‑metabolizing enzymes/efflux transporters in rats. Materials and Methods: Sprague‑Dawley rats were given baicalin (50 mg/kg BW or 100 mg/kg BW) or 0.9% sodium chloride solution by intragastric administration for 7 days. They were then fed florfenicol by intragastric administration (25 mg/kg BW) on the 8th day. Blood samples were collected at various times, and the plasma concentrations of florfenicol were estimated with ultra‑high performance liquid chromatography. The mRNA expression levels of cytochrome P450 (CYP) CYP1A2, CYP2C11, CYP3A1, UDP‑glucuronosyltransferase 1A (UGT1A), multidrug resistance 1, and ATP‑binding cassette C2 (ABCC2) in the liver and jejunum were analyzed with a real‑time polymerase chain reaction. Results: The area under the concentration‑time curve from zero to infinity, mean residence time from zero to infinity, elimination half‑life, and peak concentration of florfenicol were significantly increased and the apparent volume of distribution fraction of the dose absorbed and plasma clearance fraction of the dose absorbed were significantly decreased by baicalin; the mRNA expression levels of CYP1A2, CYP2C11, CYP3A1, UGT1A1, and ABCC2 were down‑regulated by baicalin. Conclusion: Baicalin affected the pharmacokinetics of florfenicol in rats, increased the plasma concentration and residence time of florfenicol, probably by decreasing the mRNA expression levels of CYP1A2, CYP2C11, CYP3A1, UGT1A1, and ABCC2 in the liver and jejunum.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Li, S., Li, X., Wang, B., Yang, R., Zhang, M., Li, J., Huang, W., Cao, L., & Xiao, S. (2020). Effects of Baicalin on Pharmacokinetics of Florfenicol and mRNA Expression of CYP1A2, CYP2C11, CYP3A1, UGT1A1, MDR1, and ABCC2 in Rats. Pharmacognosy Magazine, 16(67), 1–6. https://doi.org/10.4103/pm.pm_261_19
